NBIX Neurocrine Biosciences PE ratio, current and historical analysis

As of Aug 8, 2025, the NBIX stock has a PE ratio of 35.92. The calculation is based on the latest EPS of $3.48 and the stock price of $125.01 per share. The PE ratio currently is comparable to its last four-quarter average.

NBIX PE ratio history

How has NBIX's PE ratio performed in the past

The mean historical PE ratio of Neurocrine Biosciences over the last seven years is 172.19. The current 35.92 P/E ratio is 79% lower than the historical average. Looking back at the last seven years, NBIX's PE ratio peaked in the Sep 2018 quarter at 1,229.5, with a price of $122.95 and an EPS of $0.1. The Sep 2021 quarter marked the lowest point at 20.11, with a price of $95.91 and an EPS of $4.77.

Today
35.92
Average
172.19
Median
54.95
Minimum
20.11
Maximum
1,229.5

Neurocrine Biosciences PE ratio by year

Maximum annual increase: 648% in 2012

Maximum annual decrease: -91.86% in 2020

Year PE ratio PE change Price EPS
2024 40.15 -21.99% $136.5 $3.4
2023 51.47 -30.62% $131.76 $2.56
2022 74.19 -17.24% $119.44 $1.61
2021 89.65 309.73% $85.17 $0.95
2020 21.88 -91.86% $95.85 $4.38
2019 268.73 -13.45% $107.49 $0.4
2018 310.48 N/A $71.41 $0.23
2017 N/A N/A $77.59 -$1.62
2016 N/A N/A $38.7 -$1.63
2015 N/A N/A $56.57 -$1.05
2014 N/A N/A $22.34 -$0.81
2013 N/A N/A $9.34 -$0.69
2012 93.5 648% $7.48 $0.08
2011 12.5 N/A $8.5 $0.68
2010 N/A N/A $7.64 -$0.15

Neurocrine Biosciences PE ratio by quarter (TTM)

Year PE ratio PE change Price EPS
Jun 2025 36.12 -1.04% $125.69 $3.48
Mar 2025 36.5 -9.09% $110.6 $3.03
Dec 2024 40.15 34.51% $136.5 $3.4
Sep 2024 29.85 -25.64% $115.22 $3.86
Jun 2024 40.14 9.73% $137.67 $3.43
Mar 2024 36.58 -28.93% $137.92 $3.77
Dec 2023 51.47 -10.33% $131.76 $2.56
Sep 2023 57.4 11.39% $112.5 $1.96
Jun 2023 51.53 -65.89% $94.3 $1.83
Mar 2023 151.07 103.63% $101.22 $0.67
Dec 2022 74.19 -57.39% $119.44 $1.61
Sep 2022 174.11 -76.78% $106.21 $0.61
Jun 2022 749.85 507.86% $97.48 $0.13
Mar 2022 123.36 37.6% $93.75 $0.76
Dec 2021 89.65 345.8% $85.17 $0.95

NBIX Price vs fair value

How does NBIX's price compare to its estimated fair value based on its growth

NBIX average PE ratio chart

What is the average PE ratio of NBIX for the past years

NBIX's current PE ratio is lower than its 3, 5 and 10-year averages.

3-year avg
64.93
5-year avg
96.33
10-year avg
172.19
15-year avg
145.27

NBIX PE vs peers

What is NBIX's PE ratio compared to its peers

In comparison to its peers LLY and ABBV, NBIX's PE ratio is lower, but it is higher than PFE's and RPRX's.

Stock name PE ratio Market cap
PFE Pfizer Inc 13.01 $139.75B
RPRX Royalty Pharma plc 16.27 $21.92B
NBIX Neurocrine Biosciences Inc 35.92 $12.4B
LLY ELI LILLY & Co 40.76 $592.15B
ABBV AbbVie Inc 93.86 $349.87B
RGEN Repligen Corp N/A $6.27B
ANIP Ani Pharmaceuticals Inc N/A $1.77B
CASI CASI Pharmaceuticals Inc N/A $25.25M

Frequently asked questions

What is Neurocrine Biosciences's PE ratio?

The price to earnings ratio for NBIX stock is 35.92 as of Aug 8, 2025.

What is the 3-year average PE ratio for Neurocrine Biosciences (NBIX)?

Over the last 3 years, the average price to earnings ratio for NBIX stock is 64.93.

What is the 5-year average PE ratio for Neurocrine Biosciences (NBIX)?

Over the last 5 years, the average price to earnings ratio for NBIX stock is 96.33.

What is the highest PE ratio for NBIX?

The highest quarterly PE ratio in the last seven years has been 1,229.5 and it was in the Sep 2018 quarter.

How does the current PE ratio for NBIX compare to its historical average?

NBIX's current price to earnings ratio is 79% below its 7-year historical average.

How is NBIX's PE ratio calculated (Neurocrine Biosciences PE ratio formula)?

The P/E ratio is calculated by taking the latest stock price and dividing it by the EPS for the last 12 months. As of today (Aug 8, 2025), Neurocrine Biosciences's share price is $125.01. The company's earnings per share for the trailing twelve months (TTM) ending Jun 2025 is $3.48. Therefore, Neurocrine Biosciences's PE ratio for today is 35.92. PE RATIO(35.92) = STOCK PRICE($125.01) / TTM EPS($3.48)

All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.